New Report “Biochips Market Trends & Global Forecast (2010-2015)” Published by MarketPublishers.com25 Aug 2011 • by Natalie Aster
LONDON – The global biochip market is expected to reach $5.6 billion by 2015, growing at a CAGR of 16.7%, which is mainly attributed to increasing applications in cancer diagnostics and expression profiling, the boom in personalized medicine, and government funding.
DNA microarrays will continue to be the largest contributor to the market during the study period, though closely followed by lab-on-chip (LOC) in the coming years. Protein microarrays will be the fastest growing segment and forecast to grow at a CAGR of 19.9% due to advances in the fields of genomics and proteomics as well as improvements in the field of recombinant proteins.
The Asian market will account for a bulk of the future biochip market growth due to its high growth potential and huge demand from emerging economies such as India and China.
New market research report “Biochips Market (DNA Microarrays, Lab-on-Chip, Protein Microarrays, Tissue & Cell Arrays) Trends & Global Forecast (2010-2015)” worked out by MarketsandMarkets gives true insights into the global biochips market, providing its categorization on the basis of applications, types, and geography as well as forecasting revenues and analyzing trends in each of its submarkets. Each section of the study also contains market data, market drivers, trends and opportunities, top-selling products, profiles of leading players, and competitive outlook. Furthermore, covering the sub-segments market tables as well as over 20 company profiles are also incorporated in the review.
Title: Biochips Market (DNA Microarrays, Lab-on-Chip, Protein Microarrays, Tissue & Cell Arrays) Trends & Global Forecast (2010-2015)
Date: August, 2011
Price: US$ 4,650.00
1.1 KEY TAKE-AWAYS
1.2 REPORT DESCRIPTION
1.3 MARKETS COVERED
1.5 RESEARCH METHODOLOGY
1.5.1 MARKET SIZE
1.5.2 KEY DATA POINTS FROM SECONDARY SOURCES
1.5.3 KEY DATA POINTS FROM PRIMARY SOURCES
1.5.4 MARKET SHARE
1.5.5 ASSUMPTIONS MADE FOR THE REPORT
2 EXECUTIVE SUMMARY
2.1 OVERVIEW OF THE MARKET
2.2 KEY FINDINGS
2.3.1 APPLICATION OF REVERSE PHASE PROTEIN MICROARRAYS IN CANCER DIAGNOSIS IS A LUCRATIVE INVESTMENT OPTION
3 MARKET OVERVIEW
3.2 BURNING ISSUE
3.2.1 EMERGENCE OF NEW DISEASES & DISEASE COMPLEXITY CATALYZE ADOPTION OF BIOCHIPS IN DIAGNOSTICS
To order the report or ask for free sample pages, please contact email@example.com
The Market Publishers, Ltd.
Tel: +44 208 144 6009
Fax: +44 207 900 3970